Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression

• Status: Unknown status
• Trial end date: 2018-06-30
• Target enrollment: 0
• Participant gender: All

Summary

This trial attempts to evaluate the treatment efficacy of Simplified Cognitive Behavioral Therapy (SCBT) and its safety among schizophrenia patients. Half of participants will be randomized to accept SCBT.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Mental Health Center
• Collaborators: Changhai Hospital; Fudan University; Second Hospital of Shanxi Medical University; Shanghai 10th People's Hospital; Tongji Hospital

Criteria

Inclusion Criteria:

• 1. Adults aged 18-60 years old, male and female; 2. With primary school or above education levels; 3. Without vision, hearing or communication difficulties; 4. DSM-V diagnosis of generalized anxiety disorder and/or major depressive disorder; 5. HAMA-14 score greater than or equal to 14 points, less than 29 pionts; HAMD-17 score greater than or equal to 7 points, less than 24 points; 6. GAD-7 score greater than or equal to 5 points; PHQ-9 score greater than or equal to 5 points; 7. In the last 2 months, did not accept other forms of psychological treatment, or treatment is ineffective; 8. Voluntarily participate in and sign informed consent.

Exclusion Criteria:

1. Suffering from serious physical illness;

2. Having self-injurious behavior, suicidal tendencies;

3. Having bipolar disorder;

4. Having psychotic symptoms;

5. Having obsessive-compulsive disorder, post-traumatic stress disorder;

6. Pregnant women or lactating women.